Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Clinical trial NCT04827563 · TERMINATED

Trial details

NCT number: NCT04827563
Sponsor: University of Chicago
Status: TERMINATED
Study type: OBSERVATIONAL

Multiple Myeloma Shortness of Breath Dyspnea Cardiotoxicity

Start date: 2021-03-22
Primary completion: 2025-09-08
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.